Pseudoprogression Possible in Enzalutamide-Treated mCRPC – Renal and Urology News
In mCRPC, pseudoprogression or bone scan flare can be misinterpreted as enzalutamide failure and lead to premature discontinuation of therapy.
Related Articles
Inside Men’s Health: A Clinician’s View
In this episode of AUA Inside Tract, join Dr. Petar Bajic, director of Men’s Health, and Dr. Raevti Bole, Men’s Health specialist, from the Cleveland…
2025 Fundamentals in Urology Lunch n’ Learn
🎙️ New to streaming or looking to level up? Check out StreamYard and get $10 discount! 😍 https://streamyard.com/pal/d/5406675905806336
2025 Annual Meeting – Las Vegas
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence…
AUA Data Research Program – American Urological Association
Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative…
AUAUniversity Podcast Series | AUA University
AUAUniversity · AUAUniversity PodcastEpisodes 216-220Episode 218: AUA2023: What the General Urologist Should Know about Care of Transgender Patients Episode 217: AUA2023: Refractory Overactive Bladder: How…
Rising Stars in Urology Research Awards – American Urological Association
The Rising Stars in Urology Research Award program provides up to five years of supplemental salary support to urologists who have successfully competed for career development…
Sexual Health: Efficacy and Safety Of On-Demand Therapy With Clomipramine/Sildenafil Combination
Premature ejaculation (PE) is the most common male sexual dysfunctions with various treatment options. Clomipramine is commonly used for PE, and is considere…
AUA Innovation Nexus – American Urological Association
The only urology-specific incubator of its kind, Innovation Nexus is a powerful forum for advanc ing urologic discovery to solutions that improve patient care and…
Member Benefits & Programs – American Urological Association
2023 Dues ($USD) $589 * $115 * $349, $314, $278 ◊ $150, $75, $50 ◊ $209 ^ $209 $209 $0 * Dues for Active/Associate members…
CLINICAL TRIALS A Primer on Clinical Trials for Urologists, Part 2: The FDA – American Urological Association
The FDA was founded in 1906 and is a federal agency of the US Department of Health and Human Services that is responsible for protecting…